Lupin has announced the launch of Clobetasol Propionate Ointment USP 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin's Clobetasol Propionate Ointment USP, 0.05% is the generic equivalent of Fougera Pharmaceuticals Inc.'s Temovate Ointment, 0.05%. It is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Clobetasol Propionate Ointment USP 0.05% had annual sales of approximately USD 93.4 million in the US (IQVIA MAT June 2018).
Shares of LUPIN LTD. was last trading in BSE at Rs.865.5 as compared to the previous close of Rs. 847.3. The total number of shares traded during the day was 134561 in over 3339 trades.
The stock hit an intraday high of Rs. 879.9 and intraday low of 845.5. The net turnover during the day was Rs. 115962416.